Clinical trial
Lapdap and Coartemether for Uncomplicated Malaria
NCT00118794 · London School of Hygiene and Tropical Medicine, Other · Completed
Key facts
| NCT number | NCT00118794 |
|---|---|
| Title | Lapdap and Coartemether for Uncomplicated Malaria |
| Official title | Randomized Trial of the Safety and Effectiveness of Lapdap and Coartemether for Uncomplicated Malaria in Operational Settings |
| Lead sponsor | London School of Hygiene and Tropical Medicine, Other |
| Collaborators | Medical Research Council National Malaria Control Programme, The Gambia |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | Chlorproguanil-dapsone (Lapdap), Lumefantrine-artemether (Coartemether ) |
| Enrollment | 1,200 |
| Start date | Sep 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | Jul 12, 2005 |
| Last update posted | Feb 1, 2006 |
| Countries | The Gambia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: